Let us look at some biotech stocks, AMGN, CRSP, MRNA, SRPT and VRTX, which are poised to beat on fourth-quarter earnings.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Artificial intelligence (AI) is transforming various industries as a major investing theme in 2025. The technology's ability ...

Let's look at five pharma and drug companies, MRK PFE, LLY, AMGN and BMY, which are scheduled to release their fourth-quarter ...

AbbVie, Danaher, Vertex Pharmaceuticals, Cencora, GSK, Thermo Fisher Scientific, and Moderna are the seven Biotech stocks to watch today, according to MarketBeat’s stock screener tool. Biotech stocks ...

Illumina's revenue has stagnated or declined for several years now, and its total sales for 2024 were $4.3 billion, down from ...

Cathie Wood and Ark Invest sold roughly $7,379,804 worth of Palantir stock — and spent $9,145,824 on three biotech stocks.

The health sector had 21 companies reporting their quarterly earnings this week, with 18 of them beating profit estimates for the quarter. Quarter-To-Date, The Health Care Select Sector SPDR Fund ETF ...

Amgen reported strong fourth-quarter earnings, driven by strategic acquisitions and robust product sales growth.

Analysts at Zacks Small Cap boosted their Q1 2025 earnings per share (EPS) estimates for shares of Evaxion Biotech A/S in a research report issued on Wednesday, February 5th. Zacks Small Cap analyst B ...

Shares of Amgen (AMGN) fell in after-hours trading after the biotechnology company reported earnings for its fourth quarter ...